HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Production of aralin, a selective cytotoxic lectin against human transformed cells, in callus culture of Aralia elata.

Abstract
Recently we found that aralin, a novel lectin, from Aralia elata selectively induces apoptosis in human virus-transformed and cancer cells compared with normal cells. To overcome the reduction of aralin biosynthesis according to the development of leaves, we established callus tissues from the young shoots. The N-terminal amino acid sequence and immunochemical analyses revealed that ca-aralin, an aralin synthesized in the callus, was structurally identical with aralin except for the glycosylation of the B chain. The selective cytotoxic index (ratio of IC50 value against human lung normal cells versus virus-transformed cells) of ca-aralin was 2-fold higher than that of aralin. Thus, these results suggest that ca-aralin is more useful than aralin as an anticancer agent.
AuthorsMakoto Tomatsu, Toshiyuki Mujin, Norio Shibamoto, Fumio Tashiro, Akira Ikuta
JournalPlanta medica (Planta Med) Vol. 70 Issue 5 Pg. 469-71 (May 2004) ISSN: 0032-0943 [Print] Germany
PMID15124096 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents, Phytogenic
  • Lectins
  • Plant Extracts
  • Ribosome Inactivating Proteins, Type 2
  • aralin
Topics
  • Antineoplastic Agents, Phytogenic (administration & dosage, pharmacology, therapeutic use)
  • Aralia
  • Cell Transformation, Viral (drug effects)
  • Culture Techniques
  • Humans
  • Inhibitory Concentration 50
  • Lectins (administration & dosage, pharmacology, therapeutic use)
  • Lung (cytology, drug effects)
  • Phytotherapy
  • Plant Extracts (administration & dosage, pharmacology, therapeutic use)
  • Plant Shoots
  • Ribosome Inactivating Proteins, Type 2
  • Tumor Cells, Cultured (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: